BEACON CRC: A randomized, 3-Arm, phase 3 study of Encorafenib (ENCO) and Cetuximab (CETUX) with or without Binimetinib (BINI) versus choice of either Irinotecan or FOLFIRI plus Cetuximab in BRAF V600E-mutant metastatic colorectal cancer
Year: 2019
Type: article
Authors: Jayesh Desai, Scott Kopetz, Axel Grothey, Eric Van Cutsem, Rona Yaeger, Harpreet Wasan, Takayuki Yoshino, Fortunato Ciardello, Ashwin Gollerkeri, Kati Maharry, Fotios Loupakis, Yong Sang Hong, Neeltje Steeghs, Tormod K. Guren, Hendrik‐Tobias Arkenau, Pilar Alfonso, Timothy Price, Andrew Strickland, Niall C. Tebbutt, Christos S. Karapetis, Lorraine A. Chantrill, Felicity Murphy, Victor Sandor, Janna Christy‐Bittel, Lisa Anderson, Josep Tabernero
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3108778884